SLDB — SOLID BIOSCIENCES INC

Ownership history in Birchview Capital, LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in SOLID BIOSCIENCES INC (SLDB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.33% (2025 Q4)
Avg. % of fund
1.25%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 705,955 +409,000 +137.7% 2.33% $4.0M $5.64
2025 Q3 ADDED 296,955 +118,187 +66.1% 1.38% $1.8M $6.17
2025 Q2 ADDED 178,768 +50,000 +38.8% 0.86% $871K $4.87
2025 Q1 INITIATED 128,768 — — 0.41% $476K $3.70
% of Fund (quarterly)    SLDB price (monthly, adj. close)

Other funds also holding SLDB

As of 2025 Q4 — sorted by position size

Monashee Investment Management LLC 3Y 7Y 4.29% Bain Capital Life Sciences Investors, LLC 3Y 7Y 3.42% Ally Bridge Group (NY) LLC 3Y 2.43% Siren, L.L.C. 1.29% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.19% Vestal Point Capital, LP 1.12% Redmile Group, LLC 3Y 7Y 0.77% Knott David M Jr 3Y 0.42% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.34% Nantahala Capital Management, LLC 3Y 7Y 0.3%
← Back to Birchview Capital, LP Holdings